189 related articles for article (PubMed ID: 18417041)
21. Expansion of the criteria for living donor liver transplantation for hepatocellular carcinoma.
Lee HW; Suh KS
Curr Opin Organ Transplant; 2016 Apr; 21(2):231-7. PubMed ID: 26918880
[TBL] [Abstract][Full Text] [Related]
22. Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation.
Chok KSH; Chan ACY; Fung JYY; Dai WC; Cheung TT; Lo CM
Hepatol Int; 2017 Nov; 11(6):517-522. PubMed ID: 28936686
[TBL] [Abstract][Full Text] [Related]
23. [Living donor liver transplantation].
Tanaka K; Kaihara S
Chirurg; 2003 Oct; 74(10):944-50. PubMed ID: 14605737
[TBL] [Abstract][Full Text] [Related]
24. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation.
Bhangui P; Vibert E; Majno P; Salloum C; Andreani P; Zocrato J; Ichai P; Saliba F; Adam R; Castaing D; Azoulay D
Hepatology; 2011 May; 53(5):1570-9. PubMed ID: 21520172
[TBL] [Abstract][Full Text] [Related]
25. Living-donor liver transplantation: present status and future perspective.
Shimada M; Fujii M; Morine Y; Imura S; Ikemoto T; Ishibashi H
J Med Invest; 2005 Feb; 52(1-2):22-32. PubMed ID: 15751270
[TBL] [Abstract][Full Text] [Related]
26. Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma Within or Beyond the Milan Criteria: Comparable Long-Term Outcomes.
Lee S; Song GW; Kim KW; Kwon JH; Lee SG
Transplant Proc; 2021; 53(1):92-97. PubMed ID: 33288309
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.
Ng KK; Lo CM; Chan SC; Chok KS; Cheung TT; Fan ST
J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):548-54. PubMed ID: 19760139
[TBL] [Abstract][Full Text] [Related]
28. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
Reichman TW; Katchman H; Tanaka T; Greig PD; McGilvray ID; Cattral MS; Renner EL; Selzner M; Ghanekar A; Levy G; Grant DR
Transpl Int; 2013 Aug; 26(8):780-7. PubMed ID: 23746118
[TBL] [Abstract][Full Text] [Related]
29. Is recurrent hepatitis C worse with living donors?
Kuo A; Terrault NA
Curr Opin Organ Transplant; 2009 Jun; 14(3):240-4. PubMed ID: 19395968
[TBL] [Abstract][Full Text] [Related]
30. Living donor liver transplant for fibrolamellar hepatocellular carcinoma using a deceased donor graft to reconstruct inferior vena cava.
Slater K; Bak TE; Kam I; Wachs ME
Liver Transpl; 2004 Apr; 10(4):555-6. PubMed ID: 15048801
[TBL] [Abstract][Full Text] [Related]
31. Current Status of Living Donor Liver Transplantation: Impact, Advantages, and Challenges.
Liu H; Ashwat E; Humar A
Curr Gastroenterol Rep; 2023 Oct; 25(10):225-231. PubMed ID: 37603108
[TBL] [Abstract][Full Text] [Related]
32. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
[TBL] [Abstract][Full Text] [Related]
33. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
[TBL] [Abstract][Full Text] [Related]
34. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-centre comparison of living donor and deceased donor transplantation.
Hu Z; Qian Z; Wu J; Zhou J; Zhang M; Zhou L; Zheng S
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):315-326. PubMed ID: 26382281
[TBL] [Abstract][Full Text] [Related]
36. Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization.
Lentine KL; Tanaka T; Xiao H; Bittermann T; Dew MA; Schnitzler MA; Olthoff KM; Locke JE; Emre S; Hunt HF; Liapakis A; Axelrod DA
Clin Transplant; 2023 Jul; 37(7):e14924. PubMed ID: 36733213
[TBL] [Abstract][Full Text] [Related]
37. Section 2. Small-for-size liver graft and hepatocellular carcinoma recurrence.
Chan SC
Transplantation; 2014 Apr; 97 Suppl 8():S7-S10. PubMed ID: 24849840
[TBL] [Abstract][Full Text] [Related]
38. Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.
Humar A; Ganesh S; Jorgensen D; Tevar A; Ganoza A; Molinari M; Hughes C
Ann Surg; 2019 Sep; 270(3):444-451. PubMed ID: 31305283
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
Schmeding M; Neumann UP; Puhl G; Bahra M; Neuhaus R; Neuhaus P
Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
[TBL] [Abstract][Full Text] [Related]
40. Living donor liver transplantation for hepatitis C.
Takada Y; Uemoto S
Surg Today; 2013 Jul; 43(7):709-14. PubMed ID: 23052749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
